What are the specifications of molotinib?

The specification information of molotinib is as follows: Tablets are available in three specifications: 100mg, 150mg and 200mg. The drug is developed and produced by GlaxoSmithKline (GSK) and is mainly used to treat patients with myelofibrosis and anemia. Since it is a drug, the specific specifications mainly involve the dosage and method of taking the drug. According to the condition and doctor's advice, patients need to take it on time and in the right amount. Typically, the recommended dose is 200 mg taken orally once daily. For patients with severe hepatic impairment (Child-Pugh class C), the recommended starting dose is 150 mg orally once daily. Before using molotinib, patients should consult their doctor and read the drug instructions carefully to ensure the correct and safe use of the drug. At the same time, please purchase drugs through formal channels to ensure the quality and authenticity of the drugs.